Home › Funds › Harpswell Capital Advisors, LLC › RCEL

Harpswell Capital Advisors, LLC position in RCEL

AVITA MEDICAL INC · Health Care

Harpswell Capital Advisors, LLC reported holding 12,822 shares of RCEL (AVITA MEDICAL INC) in its Q3 2026 13F filing — a position valued at US$150K, representing 0.10% of its reported portfolio and ranking #42 among its reported holdings. Harpswell Capital Advisors, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)12.82K sh
Reported value held$150.40K
Portfolio Weight0.10%
First reportedQ3 2026
Last changeNew
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Harpswell Capital Advisors, LLC's RCEL position evolved

Harpswell Capital Advisors, LLC first disclosed a stake in RCEL in Q3 2026 at 12,822 shares (US$150K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 12.82K $150.40K New

About RCEL and 13F data

RCEL (AVITA MEDICAL INC) is a Health Care company. 21 other funds we track also report a position in RCEL. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RCEL

No other tracked fund reports a position in RCEL.

All RCEL fund holders →

FAQ

How long has Harpswell Capital Advisors, LLC held RCEL?

Harpswell Capital Advisors, LLC has disclosed RCEL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Harpswell Capital Advisors, LLC's current position in RCEL?

As of Q3 2026, Harpswell Capital Advisors, LLC holds 12.82K shares of RCEL (AVITA MEDICAL INC), valued at $150.40K, representing 0.10% of its reported portfolio and ranking #42.

Has Harpswell Capital Advisors, LLC been buying or selling RCEL?

In the latest 13F filing (Q3 2026), Harpswell Capital Advisors, LLC newly opened its position in RCEL.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.